Abstract | BACKGROUND: AIM: METHODS: Twenty-nine patients (6 type 1 and 23 type 2) with gastroparesis underwent assessments of: (i) gastric emptying of a solid/liquid meal using scintigraphy, (ii) glycaemic control (blood glucose at 0, 30, 60, 90 and 120 min during the gastric emptying measurement) and (iii) upper gastrointestinal and 'meal-related' symptoms (questionnaire), at baseline and after treatment with KC 11458 in a dose of 8 mg t.d.s., or placebo for 8 days. RESULTS:
KC 11458 had no statistically significant or clinically relevant effect on gastric emptying of either the solid intragastric retention at 100 min (T100) (P = 0.87) or liquid 50% emptying time (T50) (P = 0.17) components of the meal. KC 11458 slightly worsened (P = 0.04) upper gastrointestinal symptoms when compared with placebo. The magnitude of the change in solid gastric emptying correlated with the change in the blood glucose concentration (r = 0.49; P < 0.05). CONCLUSIONS:
KC 11458, in a dose of 8 mg t.d.s. for 8 days, does not accelerate gastric emptying in patients with diabetic gastroparesis. The absence of efficacy may relate to an effect of hyperglycaemia.
|
Authors | A Russo, J E Stevens, N Giles, G Krause, D G O'Donovan, M Horowitz, K L Jones |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 20
Issue 3
Pg. 333-8
(Aug 01 2004)
ISSN: 0269-2813 [Print] England |
PMID | 15274670
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- KC 11458
- Motilin
- Erythromycin
|
Topics |
- Autonomic Nervous System Diseases
(blood, physiopathology)
- Blood Glucose
(metabolism)
- Diabetes Mellitus
(blood, physiopathology)
- Diabetic Neuropathies
(blood, physiopathology)
- Erythromycin
(analogs & derivatives, pharmacology)
- Female
- Gastric Emptying
(drug effects)
- Gastroparesis
(blood, physiopathology)
- Humans
- Male
- Middle Aged
- Motilin
(antagonists & inhibitors)
|